Cargando…
SMYD3 promotes colon adenocarcinoma (COAD) progression by mediating cell proliferation and apoptosis
Colon adenocarcinoma (COAD) is a type of common malignant tumor originating in the digestive tract. Recently, targeted therapy has had significant effects on the treatment of COAD. However, more effective molecular targets need to be developed. SET and MYND domain-containing protein 3 (SMYD3) is a t...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472017/ https://www.ncbi.nlm.nih.gov/pubmed/32934676 http://dx.doi.org/10.3892/etm.2020.9139 |